Understanding Type 2 Diabetes, APOC3, and Heart Disease
Official title: Project 1. Type 2 diabetes, APOC3 and cardiovascular disease
Funded at University of Washington · NIH-11096556 · Data updated 2026-11-12
This work explores how a protein called APOC3 contributes to heart disease in people with type 2 diabetes.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | August 15, 2020 |
| Project end | July 31, 2030 |
| Funding year | 2025 |
| Award (this year) | $633,102 |
| NIH project number | 2P01HL151328-06 |
| Project ID | NIH-11096556 on NIH RePORTER |
Who could benefit from this research
✓Could help
This foundational work is for anyone interested in the underlying causes of heart disease in type 2 diabetes, particularly those with a family history or personal experience with these conditions.
✕Less likely to help
Patients seeking immediate new treatments or direct clinical intervention will not find that benefit from this basic science project.
What this research studies
We know that people with type 1 or type 2 diabetes face a much higher risk of early heart disease, and this risk is partly due to how their bodies handle certain fats, not just blood sugar or LDL cholesterol. This project looks at a specific protein, APOC3, which is linked to these fats and seems to predict heart disease in people with diabetes. We are trying to understand how certain immune cells in the body influence the liver's production of APOC3 and how these APOC3-rich fats affect the cells involved in heart disease. Our goal is to uncover the exact ways APOC3 contributes to heart disease in type 2 diabetes.
Why it matters
Potential benefit: If successful, this work could lead to new ways to prevent or treat heart disease in people with diabetes by targeting APOC3 or related pathways.
How similar studies have gone: Previous work has shown that reducing APOC3 can prevent atherosclerosis in mouse models of diabetes, suggesting this is a promising area of focus.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Bornfeldt, Karin E — University of Washington
- Study coordinator: Bornfeldt, Karin E
Related research
Other NIH-funded projects on the same topics.
-
Understanding how APOC3 affects heart disease in diabetes
This grant studies how a protein called APOC3 influences heart disease risk in people with diabetes, aiming to find ways to reduce that risk.
-
Reducing heart disease and diabetes risk in rural families
This study is looking for families in rural areas, especially those with Hispanic backgrounds, to try out a new program that helps everyone make healthier lifestyle choices together, aiming to reduce heart disease and diabetes in a fun and lasting way.
-
Understanding cardiovascular disease and type 2 diabetes in older adults
This study is looking at ways to help older adults with heart disease and type 2 diabetes by finding new ways to prevent complications and improve their care, while also training new researchers to carry out important health studies.
-
Subtyping Core for Research on the Causes of Type 2 Diabetes (SCORE-T2D)
A new U01 grant from a university research team aims to understand why Type 2 diabetes differs so much between people and how to tailor prevention and treatment.
-
Michigan Diabetes Project: A Peer-Led Self-Management Program for Adults with Type 2 Diabetes
A peer-led self-management program for adults with type 2 diabetes is being tested to see if it improves blood sugar control and daily diabetes care.
-
Alzheimer’s and dementia risk in people with prediabetes or type 2 diabetes
This grant aims to understand why some older adults with prediabetes or type 2 diabetes develop memory problems or dementia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.